Five Mountains Pharma Private Limited
About Five Mountains Pharma Private Limited
Data last updated:
Five Mountains Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2022PTC378135. Its GSTIN is 27AAECF9584H1Z4 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Alagarswamy Kandhaswamy Raja and Anglis Aruldoss Daniel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No 126A Lower Ground Floor Eaze Zone Mall Off Link Rd Malad South, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.87 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹42,407 (net margin -11%) and EBITDA of -₹42,407 (EBITDA margin -11%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 126A Lower Ground Floor Eaze Zone Mall Off Link Rd Malad South, Mumbai, Maharashtra, India – 400064
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Five Mountains Pharma Private Limited FY 2024 filings available
Five Mountains Pharma Private Limited reported revenue of ₹3.87 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Five Mountains Pharma Private Limited
Revenue rose 1% in the latest year. EBITDA rose 94% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Five Mountains Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹42,407 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹42,407 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Five Mountains Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -11% | •••• | •••• |
| Net Profit Margin | -11% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Five Mountains Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Five Mountains Pharma Private Limited
Five Mountains Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alagarswamy Kandhaswamy Raja Also directs: Wineela International Private Limited | Director | 09 Mar 2022 | 4 Years 7 Months | Current |
| Anglis Aruldoss Daniel | Director | 21 Jan 2026 | 0 Years 8 Months | Current |
Charges & Borrowings of Five Mountains Pharma Private Limited
Five Mountains Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Five Mountains Pharma Private Limited
Employment history and EPFO contributions of people linked to Five Mountains Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Five Mountains Pharma Private Limited
Five Mountains Pharma Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Anglis Aruldoss Daniel was appointed as Director on 21 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for Five Mountains Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Five Mountains Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Five Mountains Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Five Mountains Pharma Private Limited
Five Mountains Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECF9584H1Z4 | Maharashtra | Active | 30 Mar 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Five Mountains Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Five Mountains Pharma Private Limited
Five Mountains Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2022 (4+ years old) and is registered under CIN U24232MH2022PTC378135.
Five Mountains Pharma reported revenue of ₹3.87 Lakh for FY 2024 (up 1% YoY).
Five Mountains Pharma has 2 current directors:
- Alagarswamy Kandhaswamy Raja - Director
- Anglis Aruldoss Daniel - Director
Five Mountains Pharma reported a net loss of ₹42,407 (net margin -11%) and EBITDA of -₹42,407 (EBITDA margin -11%) for FY 2024, as per its filed financial statements.
The GSTIN of Five Mountains Pharma is 27AAECF9584H1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Five Mountains Pharma is U24232MH2022PTC378135. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Five Mountains Pharma was incorporated on 09 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Anglis Aruldoss Daniel was appointed as Director on 21 Jan 2026. Hayathkhan Ahamed Faizal ceased to be Director on 15 Jul 2023. Selvabalaji Harikrishnan was appointed as Director on 15 Jul 2023. Five Mountains Pharma has 5 board changes on record in total.
The registered office of Five Mountains Pharma is at Shop No 126A Lower Ground Floor Eaze Zone Mall Off Link Rd Malad South, Mumbai, Maharashtra, India – 400064.
Five Mountains Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.